Literature DB >> 9053860

Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.

A G Menon1, J L Rutter, J P von Sattel, H Synder, C Murdoch, A Blumenfeld, R L Martuza, A von Deimling, J F Gusella, T W Houseal.   

Abstract

Formation of meningiomas has been associated with the loss of genetic material on chromosome 22. To approach the additional chromosomal events that underlie progression of these tumors to malignancy, we have examined several other chromosomal regions for loss of heterozygosity (LOH) in these tumors. Fifty-eight tumors, comprising 43 benign meningiomas, 11 atypical meningiomas and four malignant meningiomas, were examined. While the loss of chromosome 22 was seen in approximately half of all these tumors, regardless of their malignancy, the most frequent chromosomal losses observed in the malignant and atypical tumors were on the long arm of chromosome 14. Thirty-nine tumors were informative for at least one of the three markers on chromosome 14 that we tested. Of these, 7/14 malignant and atypical tumors showed LOH in contrast to only 1/25 benign tumors. Other loci that showed LOH in malignant tumors, although at a much lower frequency, were on chromosomes 17p and 1p. The high frequency of LOH for loci on chromosome 14q in atypical and malignant tumors suggests the presence of a tumor progression gene at this locus. In one of the malignant meningiomas heterozygosity was lost at D14S13 and D14S16 but retained at the proximal marker D14S43 as well as the more distal marker D14S23. This suggests that an interstitial deletion occurred in this tumor which should be useful for further refining the position of the putative tumor progression locus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9053860     DOI: 10.1038/sj.onc.1200853

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Molecular and genetic profiles of radiographically defined de novo meningiomas.

Authors:  Yohei Kitamura; Hikaru Sasaki; Kazunari Yoshida
Journal:  J Neurooncol       Date:  2012-01-25       Impact factor: 4.130

2.  Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression.

Authors:  Xun Zhang; Roger Gejman; Ali Mahta; Ying Zhong; Kimberley A Rice; Yunli Zhou; Pornsuk Cheunsuchon; David N Louis; Anne Klibanski
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.

Authors:  Ralf Ketter; Yoo-Jin Kim; Simone Storck; Jörg Rahnenführer; Bernd F M Romeike; Wolf-Ingo Steudel; Klaus D Zang; Wolfram Henn
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

Review 4.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

5.  Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

Authors:  R G Weber; J Boström; M Wolter; M Baudis; V P Collins; G Reifenberger; P Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?

Authors:  José María Sayagués; María Dolores Tabernero; Angel Maíllo; Ana Espinosa; Ana Rasillo; Pedro Díaz; Juana Ciudad; Antonio López; Marta Merino; Jesús María Gonçalves; Angel Santos-Briz; Francisco Morales; Alberto Orfao
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

Review 7.  Cytogenetic findings in pediatric radiation-induced atypical meningioma after treatment of medulloblastoma: case report and review of the literature.

Authors:  María Sol Brassesco; Elvis Terci Valera; Luciano Neder; Julia Alejandra Pezuk; Ricardo Santos Oliveira; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  J Neurooncol       Date:  2012-10-18       Impact factor: 4.130

8.  The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation.

Authors:  Q Gao; S Srinivasan; S N Boyer; D E Wazer; V Band
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.

Authors:  Angel Maillo; Alberto Orfao; Ana B Espinosa; José María Sayagués; Marta Merino; Pablo Sousa; Monica Lara; María Dolores Tabernero
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

10.  Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.

Authors:  Jay Jagannathan; Rod J Oskouian; Hian Kwang Yeoh; Dwight Saulle; Aaron S Dumont
Journal:  Skull Base       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.